# Krystal Biotech, Inc. (KRYS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Krystal Biotech, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/KRYS/mda/fy2025/): filed 2026-02-17; accession 0001711279-26-000016 (https://www.sec.gov/Archives/edgar/data/1711279/000171127926000016/krys-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/KRYS/mda/fy2024/): filed 2025-02-19; accession 0001711279-25-000008 (https://www.sec.gov/Archives/edgar/data/1711279/000171127925000008/krys-20241231.htm)
- [FY 2023 MD&A](/company/KRYS/mda/fy2023/): filed 2024-02-26; accession 0001711279-24-000005 (https://www.sec.gov/Archives/edgar/data/1711279/000171127924000005/krys-20231231.htm)
- [FY 2022 MD&A](/company/KRYS/mda/fy2022/): filed 2023-02-27; accession 0001711279-23-000008 (https://www.sec.gov/Archives/edgar/data/1711279/000171127923000008/krys-20221231.htm)
- [FY 2021 MD&A](/company/KRYS/mda/fy2021/): filed 2022-02-28; accession 0001711279-22-000004 (https://www.sec.gov/Archives/edgar/data/1711279/000171127922000004/krys-20211231.htm)

Back to /company/KRYS/